Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 392.00
0.00 (0.00%)
Sep 17, 2026, 1:30 PM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.35 billion as of September 17, 2026. Its market cap has decreased by -6.44% in one year.
Market Cap
21.35B
Enterprise Value
20.66B
Revenue
2.19B
Ranking
n/a
PE Ratio
26.35
Stock Price
392.00
ChartMarket Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.35B, an increase of 1,335.66%. That is a compound annual growth rate of 17.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 21.35B | -1.01% |
| Dec 31, 2025 | 21.57B | 41.43% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 20.83B |
| Medigen Vaccine Biologics | 19.10B |
| CHO Pharma | 18.16B |
| TaiMed Biologics | 16.36B |
| Ever Supreme Bio Technology | 15.51B |
| Gongwin Biopharm Holdings | 15.20B |
| EirGenix | 14.35B |
| Lumosa Therapeutics | 12.70B |